CareLit Fachartikel

Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617

K Kessel, A Breuer, R Seifert, M Schäfers, M Bögemann, K Rahbar · Nuklearmedizin - NuclearMedicine · 2019 · Heft 02

Dokument
1214032
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
K Kessel, A Breuer, R Seifert, M Schäfers, M Bögemann, K Rahbar
Ausgabe
Heft 02 / 2019
Jahrgang 58
Seiten
–
Erschienen: 2019-03-01 00:00:00
ISSN
0029-5566
DOI
10.1055/s-0039-1683558

Zusammenfassung

Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving 177Lu-PSMA-617

Schlagworte

Second Chemotherapy Visceral Metastases Associated Survival Patients Mcrpc Receiving 177Lu-Psma-617 Nuklearmedizin - NuclearMedicine